Article
AcrAB efflux pump plays a role in decreased susceptibility to tigecycline in Morganella morganii.
Antimicrobial agents and chemotherapy - 1 Feb 2005
Ruzin Alexey, Keeney David, Bradford Patricia A
Abstract excerpt
Transposon mutagenesis of a clinical isolate of Morganella morganii, G1492 (tigecycline MIC of 4 microg/ml), yielded two insertion knockout mutants for which tigecycline MICs were 0.03 microg/ml. Transposon insertions mapped to acrA, which is constitutively overexpressed in G1492, suggesting a role of the AcrAB efflux pump in decreased susceptibility to tigecycline in M. morganii.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
